The value of NT-proBNP in cardiovascular risk stratification and optimization of cardioprotective treatment among patients with type 2 diabetes.
27 August 2021 (00:00 - 00:00)
Organised by:
About the speaker
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
4 More presentations in this session
Doctor C. Puelacher (Innsbruck, AT)
Doctor K. Kemp Gudmundsdottir (Reykjavik, IS)
Access the full session
The Event
ESC Congress 2021 - The Digital Experience
27 August - 30 August 2021
